MKI67 and neoplasm: The WHO 5th recommended a two-tier risk assessment system based on the tumor’s proliferative activity and necrosis [4]: (i) mitotic counts, ≥5 cells/2 mm2; (ii) Ki67 labeling index, ≥5%; and (iii) presence of tumor necrosis (Table 3).